U.S. Gastro-Intestinal Stromal Tumors Market Report 2019: The Pipeline, Epidemiology, Market Valuations, Drugs (Sales & Market Share), and Competitive Landscape Through 2014-2024 - ResearchAndMarkets.com

DUBLIN--()--The "US Gastro-Intestinal Stromal Tumors Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive insights into Gastro-Intestinal Stromal Tumors pipeline products, Gastro-Intestinal Stromal Tumors epidemiology, Gastro-Intestinal Stromal Tumors market valuations and forecast, Gastro-Intestinal Stromal Tumors drugs sales and competitive landscape in the US.

The research is classified into seven sections - Gastro-Intestinal Stromal Tumors treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Gastro-Intestinal Stromal Tumors pipeline: Find out the products in clinical trials for the treatment of Gastro-Intestinal Stromal Tumors by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Gastro-Intestinal Stromal Tumors epidemiology: Find out the number of patients diagnosed (prevalence) with Gastro-Intestinal Stromal Tumors in the US
  • Gastro-Intestinal Stromal Tumors drugs: Identify key products marketed and prescribed for Gastro-Intestinal Stromal Tumors in the US, including trade name, molecule name, and company
  • Gastro-Intestinal Stromal Tumors drugs sales: Find out the sales revenues of Gastro-Intestinal Stromal Tumors drugs in the US
  • Gastro-Intestinal Stromal Tumors market valuations: Find out the market size for Gastro-Intestinal Stromal Tumors drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Gastro-Intestinal Stromal Tumors drugs market share: Find out the market shares for key Gastro-Intestinal Stromal Tumors drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Gastro-Intestinal Stromal Tumors market analysis and sales trends
  • Track competitor drugs sales and market share in the US Gastro-Intestinal Stromal Tumors market
  • Track competitive developments in Gastro-Intestinal Stromal Tumors market and present key issues and learnings
  • Synthesize insights for Gastro-Intestinal Stromal Tumors market and products to drive business performance
  • Answer key business questions about the Gastro-Intestinal Stromal Tumors market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Gastro-Intestinal Stromal Tumors products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Gastro-Intestinal Stromal Tumors Treatments

2) Gastro-Intestinal Stromal Tumors Pipeline

3) US Gastro-Intestinal Stromal Tumors Epidemiology

4) Marketed Drugs for Gastro-Intestinal Stromal Tumors in US

5) US Gastro-Intestinal Stromal Tumors Market Size and Forecast

6) US Gastro-Intestinal Stromal Tumors Products Sales and Forecast

7) US Gastro-Intestinal Stromal Tumors Market Competitive Landscape

8) Methodology

List of Tables

1. Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trials, 2019

2. Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trials, 2019

3. Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trials, 2019

4. Gastro-Intestinal Stromal Tumors Epidemiology, US, 2014 - 2024

5. Marketed Drugs for Gastro-Intestinal Stromal Tumors, US, 2018

6. Gastro-Intestinal Stromal Tumors Market Size and Forecast ($), US, 2014 - 2024

7. Gastro-Intestinal Stromal Tumors Product Sales ($), US, 2014 - 2024

List of Figures

1. Gastro-Intestinal Stromal Tumors Epidemiology, US, 2014 - 2024

2. Gastro-Intestinal Stromal Tumors Market Size and Forecast ($), US, 2014 - 2024

3. Gastro-Intestinal Stromal Tumors Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/nvi6g7

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Oncology Drugs